Ocular immunosuppressive microenvironment
- PMID: 17264484
- DOI: 10.1159/000099255
Ocular immunosuppressive microenvironment
Abstract
Over the past 30 years, it has become evident that within the ocular microenvironment there are active mechanisms of immunoregulation and immunosuppression. The immunoregulation and immunosuppression are mediated by the constitutive presence of neuropeptides found in aqueous humor. Each of these immunosuppressive neuropeptides contributes in its own way to suppress induction of delayed-type hypersensitivity and to induce regulatory immunity. Collectively, the neuropeptides in aqueous humor suppress the activation of Th1 cells while promoting the induction of CD25+ CD4+ regulatory T cells. The central mediator of aqueous humor regulation of immunity is the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). This ocular system of immunoregulation and immunosuppression through alpha-MSH not only suppresses immunogenic inflammation, but also actively manipulates immunity to make the immune response itself immunosuppressive.
Similar articles
-
A review of the influence of aqueous humor on immunity.Ocul Immunol Inflamm. 2003 Dec;11(4):231-41. doi: 10.1076/ocii.11.4.231.18269. Ocul Immunol Inflamm. 2003. PMID: 14704895 Review.
-
Ocular immunosuppressive microenvironment.Chem Immunol. 1999;73:72-89. doi: 10.1159/000058738. Chem Immunol. 1999. PMID: 10590575 Review. No abstract available.
-
Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor.Curr Eye Res. 1992 Dec;11(12):1199-206. doi: 10.3109/02713689208999545. Curr Eye Res. 1992. PMID: 1490338
-
Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor.J Immunol. 1994 Aug 1;153(3):1080-6. J Immunol. 1994. PMID: 8027541
-
Specific aqueous humor factors induce activation of regulatory T cells.Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2268-74. Invest Ophthalmol Vis Sci. 1999. PMID: 10476792
Cited by
-
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?Cancers (Basel). 2019 Jul 26;11(8):1055. doi: 10.3390/cancers11081055. Cancers (Basel). 2019. PMID: 31357439 Free PMC article. Review.
-
The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.Brain Behav Immun. 2008 Jul;22(5):639-46. doi: 10.1016/j.bbi.2007.11.001. Epub 2008 Jan 2. Brain Behav Immun. 2008. PMID: 18171609 Free PMC article.
-
Pigment Dispersion Contributes to Ocular Immune Privilege in a DBA/2J Mouse Model of Pigmentary Glaucoma.Invest Ophthalmol Vis Sci. 2024 Jul 1;65(8):51. doi: 10.1167/iovs.65.8.51. Invest Ophthalmol Vis Sci. 2024. PMID: 39083309 Free PMC article.
-
Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?Front Immunol. 2012 Jun 13;3:148. doi: 10.3389/fimmu.2012.00148. eCollection 2012. Front Immunol. 2012. PMID: 22707951 Free PMC article.
-
Ocular immune privilege.F1000 Biol Rep. 2010 Jan 18;2:3. doi: 10.3410/B2-3. F1000 Biol Rep. 2010. PMID: 20948803 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous